[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

ANI Pharma Inc (ANIP)

ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks

Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks

ANIP : 74.77 (-0.46%)
ANIP Q2 Deep Dive: Rare Disease Expansion Drives Growth Amid Guidance Recalibration

ANIP Q2 Deep Dive: Rare Disease Expansion Drives Growth Amid Guidance Recalibration

ANIP : 74.77 (-0.46%)
ANI Pharmaceuticals’s (NASDAQ:ANIP) Q2 CY2026 Sales Beat Estimates But Stock Drops On Weak Guidance

ANI Pharmaceuticals’s (NASDAQ:ANIP) Q2 CY2026 Sales Beat Estimates But Stock Drops On Weak Guidance

ANIP : 74.77 (-0.46%)
ANI: Q2 Earnings Snapshot

ANI: Q2 Earnings Snapshot

ANIP : 74.77 (-0.46%)
ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results

Quarterly net revenues of $266.0 million, an increase of 25.9% year-over-year Purified Cortrophin ® Gel net revenues of $117.1 million, an increase of 43.5% year-over-year ...

ANIP : 74.77 (-0.46%)
ANI Pharmaceuticals Reports Tomorrow With Wall Street Already Pricing In The Cortrophin Momentum

Barchart Research What to Expect from ANIP Earnings ANIP Generated August 6, 2026 Current Price $82.63 EPS Estimate $$1.67 Consensus Rating Strong Buy Average Move 7.23% ANI Pharmaceuticals Reports Tomorrow...

ANIP : 74.77 (-0.46%)
ANI Pharmaceuticals (ANIP) Q2 Earnings: What To Expect

ANI Pharmaceuticals (ANIP) Q2 Earnings: What To Expect

ANIP : 74.77 (-0.46%)
1 Healthcare Stock Worth Your Attention and 2 We Question

1 Healthcare Stock Worth Your Attention and 2 We Question

TECH : 72.17 (-0.08%)
LNTH : 100.94 (+0.21%)
ANIP : 74.77 (-0.46%)
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET

PRINCETON, N.J., July 24, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the Company will release its second quarter 2026 financial results...

ANIP : 74.77 (-0.46%)
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds

1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds

IART : 18.24 (+4.95%)
ANIP : 74.77 (-0.46%)
LH : 322.59 (-0.28%)

Barchart Exclusives

CEO Steve Huffman Once Said of Creating Reddit, ‘I Just Didn't Want To Look Stupid In Front Of My Parents’ — Now RDDT Stock is Joining the S&P 500 Index
What Reddit stock’s addition to the S&P 500 index means for the stock and for RDDT investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.